Serum Free Hormone Assessment is a precise clinical measurement technique that quantifies the biologically active, unbound fraction of hormones circulating in the bloodstream. Unlike total hormone measurements, the free fraction represents the portion immediately available to interact with target tissue receptors and elicit a biological effect. This assessment provides a more accurate picture of hormonal status and functional tissue exposure.
Origin
This methodology originates from the development of sensitive radioimmunoassay and equilibrium dialysis techniques in clinical chemistry and endocrinology. It became necessary when researchers realized that most circulating hormones are bound to carrier proteins, such as sex hormone-binding globulin (SHBG) or albumin, which render them temporarily inactive. The assessment corrects for the variability in these binding proteins.
Mechanism
The measurement mechanism involves physically separating the unbound hormone from the protein-bound fraction, typically through equilibrium dialysis or ultrafiltration, before quantification. The free hormone, being lipid-soluble, can readily diffuse across cell membranes to bind to intracellular receptors and modulate gene transcription. This assessment is crucial for accurate diagnosis and fine-tuning of hormone replacement therapies.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.